Glen Eagle Advisors’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.8K | Hold |
100
| – | – | ﹤0.01% | 682 |
|
|
2026
Q1 | $11.9K | Hold |
100
| – | – | ﹤0.01% | 642 |
|
|
2025
Q4 | $13.6K | Hold |
100
| – | – | ﹤0.01% | 641 |
|
|
2025
Q3 | $14.8K | Hold |
100
| – | – | ﹤0.01% | 625 |
|
|
2025
Q2 | $12.9K | Hold |
100
| – | – | ﹤0.01% | 615 |
|
|
2025
Q1 | $11.9K | Sell |
100
-107
| -52% | -$13.3K | ﹤0.01% | 613 |
|
|
2024
Q4 | $24.1K | Hold |
207
| – | – | ﹤0.01% | 531 |
|
|
2024
Q3 | $28K | Hold |
207
| – | – | ﹤0.01% | 522 |
|
|
2024
Q2 | $28K | Buy |
207
+1
| +0.5% | +$136 | 0.01% | 502 |
|
|
2024
Q1 | $26.7K | Sell |
206
-50
| -20% | -$6.04K | 0.01% | 508 |
|
|
2023
Q4 | $29.3K | Hold |
256
| – | – | 0.01% | 470 |
|
|
2023
Q3 | $23.3K | Hold |
256
| – | – | 0.01% | 503 |
|
|
2023
Q2 | $28.8K | Buy |
256
+1
| +0.4% | +$106 | 0.01% | 466 |
|
|
2023
Q1 | $26.7K | Hold |
255
| – | – | 0.01% | 467 |
|
|
2022
Q4 | $28.2K | Buy |
255
+1
| +0.4% | +$105 | 0.01% | 440 |
|
|
2022
Q3 | $22.2K | Buy |
254
+100
| +65% | +$9.09K | 0.01% | 471 |
|
|
2022
Q2 | $12K | Hold |
154
| – | – | ﹤0.01% | 586 |
|
|
2022
Q1 | $13.1K | Buy |
154
+51
| +50% | +$4.89K | ﹤0.01% | 578 |
|
|
2021
Q4 | $12.4K | Hold |
103
| – | – | ﹤0.01% | 586 |
|
|
2021
Q3 | $12.8K | Hold |
103
| – | – | ﹤0.01% | 650 |
|
|
2021
Q2 | $12.3K | Hold |
103
| – | – | ﹤0.01% | 649 |
|
|
2021
Q1 | $10.8K | Buy |
103
+1
| +1% | +$101 | ﹤0.01% | 655 |
|
|
2020
Q4 | $10.4K | Hold |
102
| – | – | ﹤0.01% | 630 |
|
|
2020
Q3 | $8.59K | Hold |
102
| – | – | ﹤0.01% | 622 |
|
|
2020
Q2 | $6.61K | Sell |
102
-224
| -69% | -$14.8K | ﹤0.01% | 627 |
|
|
2020
Q1 | $21.3K | Sell |
326
-225
| -41% | -$17.7K | 0.01% | 394 |
|
|
2019
Q4 | $43.4K | Buy |
551
+450
| +446% | +$35K | 0.02% | 333 |
|
|
2019
Q3 | $8.01K | Buy |
101
+1
| +1% | +$79 | 0.01% | 546 |
|
|
2019
Q2 | $8.39K | Buy |
+100
| New | +$7.97K | 0.01% | 530 |
|
|
2018
Q2 | – | Sell |
-40
| Closed | -$3.08K | – | 709 |
|
|
2018
Q1 | $3.08K | Hold |
40
| – | – | ﹤0.01% | 570 |
|
|
2017
Q4 | $2.73K | Hold |
40
| – | – | ﹤0.01% | 555 |
|
|
2017
Q3 | $2.5K | Hold |
40
| – | – | ﹤0.01% | 571 |
|
|
2017
Q2 | $2.22K | Sell |
40
-250
| -86% | -$13K | ﹤0.01% | 534 |
|
|
2017
Q1 | $14.5K | Buy |
290
+40
| +16% | +$1.95K | 0.01% | 326 |
|
|
2016
Q4 | $12.4K | Buy |
+250
| New | +$12.7K | 0.01% | 328 |
|
Other funds holding XYL
Glen Eagle Advisors's XYL Position: Q2 2026 in Review
Glen Eagle Advisors held its Xylem (XYL) position steady in Q2 2026 at 100 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #682.
Glen Eagle Advisors first reported a position in XYL in Q4 2016 and has held it in 35 quarters since. The position peaked at $43.4K in Q4 2019. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Glen Eagle Advisors held 100 shares of Xylem worth $11.8K as of Q2 2026.
- Glen Eagle Advisors left its Xylem share count unchanged in Q2 2026.
- Xylem made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #682 holding.
- Glen Eagle Advisors first reported a position in Xylem in Q4 2016 and has held it in 35 quarters since.
- Glen Eagle Advisors's Xylem position peaked at $43.4K in Q4 2019.
- 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.